---
$id: https://graph.org.ai/products/commodity/51142515
$type: Product
source: UNSPSC
code: "51142515"
title: "Adrogolide"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Adrogolide

**UNSPSC Code**: 51142515
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist with the molecular formula C22H25NO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YC3281G42A, chemically known as (5ar, 11bs) 4,5,5a,6,7,11b-hexahydro-2-propylbenzo(f)thienol(2,3c)quinoline-9,10-diol diacetate (ester) but generally known as adrogolide, which bears US NIH Compound Identifier 176876. Adrogolide comes in both base and hydrochloride forms. The term ADROGOLIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 3, 2000, List 44). Most nations schedule adrogolide under HS 29349990 and SITC 51579. As of Q4 2014, ADROGOLIDE remains the US FDA Preferred Term for this commodity. Adrogolide bears US NLM identifiers UMLS ID C0381061 and NCI Concept Code C73308. SMILES: CCCC1=CC2=C(S1)CNC3C2C4=CC(=C(C=C4CC3)OC(=O)C)OC(=O)C.

